发明名称 CRF1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA
摘要 CRF1 receptor antagonists have the potential to directly inhibit ACTH release in patients with CAH and thereby allow normalization of androgen production while using lower, more physiologic doses of hydrocortisone, and thus reducing treatment-associated side effects.
申请公布号 CA2936974(A1) 申请公布日期 2015.07.30
申请号 CA20152936974 申请日期 2015.01.21
申请人 NEUROCRINE BIOSCIENCES, INC. 发明人 GRIGORIADIS, DIMITRI E.
分类号 A61K31/427;A61K31/4985;A61K31/519 主分类号 A61K31/427
代理机构 代理人
主权项
地址